Alere Company
Alere provides diagnostics and health management solutions for infectious, heart and cancer-related diseases and drug addicts.
Total Funding:
$512 000 000
Headquarters:
Waltham, Massachusetts, United States
Funding Status:
M&A
Estimated Revenue:
$1B to $10B
Last Funding Type:
Post-IPO Equity
Technology:
Genetic Test & Molecular Diagnostics
Last Funding Date:
2017-08-14
Founded Date:
01.01.1981
Industry:
Diagnostics